TP53 point mutations represent the most frequent gene mutations occurring in about 50% of cases, these mutations being detectable both in EAC and ESCC; TP53 mutations are detectable also in early metaplastic precancerous lesions. This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.